New Edge Advisors, LLC Nektar Therapeutics Transaction History
New Edge Advisors, LLC
- $11.2 Billion
- Q1 2024
A detailed history of New Edge Advisors, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,500 shares of NKTR stock, worth $1,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$1,755
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NKTR
# of Institutions
128Shares Held
111MCall Options Held
150KPut Options Held
4K-
Deep Track Capital, LP Greenwich, CT18.4MShares$21.5 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$14.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA7.57MShares$8.86 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA6.97MShares$8.15 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.88MShares$6.88 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $219M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...